Literature DB >> 8348954

Cyanide-reactive sites in cytochrome bd complex from E. coli.

I Krasnoselskaya1, A M Arutjunjan, I Smirnova, R Gennis, A A Konstantinov.   

Abstract

Cyanide reacts with cytochrome bd from E. coli in an 'aerobically oxidized' state (mainly, an oxygenated complex b558(3+) b595(3+) d(2+)-O2), bringing about (i) decomposition of the heme d2+ oxycomplex (decay of the 648 nm absorption band) and (ii) extensive red shift in the Soret region accompanied by minor changes in the visible range assigned to ferric heme b595. MCD spectra show that the Soret red shift is associated with heme b595(3+) high-to low-spin transition. This is the first unambiguous demonstration that heme b595 can bind exogenous ligands. No reaction of cyanide with b558 is observed. In about 70% of the enzyme which forms the cyano complex, the spin-state transition of b595 decay of heme d oxycomplex match each other kinetically (keff ca. 0.002 s-1 at 50 mM KCN, pH 8.1, 25 degrees C). This points to an interaction between the two hemes. The concerted binding of cyanide to d3+ and b595(3+), perhaps as a bridging ligand, is probably rate-limited by d2+ oxycomplex autoxidation. In the remaining 30% of the isolated bd, there is a rapid phase of cyanide-induced b595 spin-state transition which can be tentatively assigned to that proportion of the enzyme in which heme d is initially in the ferric rather than ferrous-oxy form.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348954     DOI: 10.1016/0014-5793(93)81004-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Heme-heme and heme-ligand interactions in the di-heme oxygen-reducing site of cytochrome bd from Escherichia coli revealed by nanosecond absorption spectroscopy.

Authors:  Fabrice Rappaport; Jie Zhang; Marten H Vos; Robert B Gennis; Vitaliy B Borisov
Journal:  Biochim Biophys Acta       Date:  2010-05-28

Review 2.  The cytochrome bd respiratory oxygen reductases.

Authors:  Vitaliy B Borisov; Robert B Gennis; James Hemp; Michael I Verkhovsky
Journal:  Biochim Biophys Acta       Date:  2011-07-01

3.  Time-resolved electrometric and optical studies on cytochrome bd suggest a mechanism of electron-proton coupling in the di-heme active site.

Authors:  Ilya Belevich; Vitaliy B Borisov; Jie Zhang; Ke Yang; Alexander A Konstantinov; Robert B Gennis; Michael I Verkhovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

4.  Femtosecond resolution of ligand-heme interactions in the high-affinity quinol oxidase bd: A di-heme active site?

Authors:  M H Vos; V B Borisov; U Liebl; J L Martin; A A Konstantinov
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 5.  Oxygen reactions with bacterial oxidases and globins: binding, reduction and regulation.

Authors:  R K Poole
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

Review 6.  Bacterial Oxidases of the Cytochrome bd Family: Redox Enzymes of Unique Structure, Function, and Utility As Drug Targets.

Authors:  Vitaliy B Borisov; Sergey A Siletsky; Alessandro Paiardini; David Hoogewijs; Elena Forte; Alessandro Giuffrè; Robert K Poole
Journal:  Antioxid Redox Signal       Date:  2020-11-09       Impact factor: 7.468

7.  Mechanistic and structural diversity between cytochrome bd isoforms of Escherichia coli.

Authors:  Tamara N Grund; Melanie Radloff; Di Wu; Hojjat G Goojani; Luca F Witte; Wiebke Jösting; Sabine Buschmann; Hannelore Müller; Isam Elamri; Sonja Welsch; Harald Schwalbe; Hartmut Michel; Dirk Bald; Schara Safarian
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

8.  Structure of Escherichia coli cytochrome bd-II type oxidase with bound aurachin D.

Authors:  Antonia Grauel; Jan Kägi; Tim Rasmussen; Iryna Makarchuk; Sabrina Oppermann; Aurélien F A Moumbock; Daniel Wohlwend; Rolf Müller; Frederic Melin; Stefan Günther; Petra Hellwig; Bettina Böttcher; Thorsten Friedrich
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.